These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16477587)

  • 21. Citalopram in the treatment of women with chronic pelvic pain: an open-label trial.
    Brown CS; Franks AS; Wan J; Ling FW
    J Reprod Med; 2008 Mar; 53(3):191-5. PubMed ID: 18441724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A surveillance study of escitalopram treatment of depressed patients.
    Anders M; Tuma I; Rösslerova H
    Expert Opin Pharmacother; 2008 Jan; 9(1):1-6. PubMed ID: 18076333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escitalopram for perimenopausal depression: an open-label pilot study.
    Freeman MP; Hill R; Brumbach BH
    J Womens Health (Larchmt); 2006 Sep; 15(7):857-61. PubMed ID: 16999641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription.
    Benoit M; Andrieu S; Lechowski L; Gillette-Guyonnet S; Robert PH; Vellas B;
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):409-14. PubMed ID: 17918770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open-label trial of escitalopram in the treatment of pathological gambling.
    Black DW; Shaw M; Forbush KT; Allen J
    Clin Neuropharmacol; 2007; 30(4):206-12. PubMed ID: 17762317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Escitalopram in seasonal affective disorder: results of an open trial.
    Pjrek E; Winkler D; Stastny J; Praschak-Rieder N; Willeit M; Kasper S
    Pharmacopsychiatry; 2007 Jan; 40(1):20-4. PubMed ID: 17327956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.
    An H; Choi B; Park KW; Kim DH; Yang DW; Hong CH; Kim SY; Han SH
    J Alzheimers Dis; 2017; 55(2):727-735. PubMed ID: 27716660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of escitalopram to paroxetine in the treatment of depression.
    Kasper S; Baldwin DS; Larsson Lönn S; Boulenger JP
    Eur Neuropsychopharmacol; 2009 Apr; 19(4):229-37. PubMed ID: 19185467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humour therapy in patients with late-life depression or Alzheimer's disease: a pilot study.
    Walter M; Hänni B; Haug M; Amrhein I; Krebs-Roubicek E; Müller-Spahn F; Savaskan E
    Int J Geriatr Psychiatry; 2007 Jan; 22(1):77-83. PubMed ID: 16977676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose escitalopram for the treatment of obsessive-compulsive disorder.
    Rabinowitz I; Baruch Y; Barak Y
    Int Clin Psychopharmacol; 2008 Jan; 23(1):49-53. PubMed ID: 18090508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
    Burns A; Gauthier S; Perdomo C
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.
    Soares CN; Arsenio H; Joffe H; Bankier B; Cassano P; Petrillo LF; Cohen LS
    Menopause; 2006; 13(5):780-6. PubMed ID: 16894334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A trial of treating depressive states with cipramil].
    Iakovlev VA; Belinskiĭ AV; Dorovskikh IV
    Voen Med Zh; 2000 Jun; 321(6):53-6. PubMed ID: 10929517
    [No Abstract]   [Full Text] [Related]  

  • 36. Escitalopram therapy for major depression and anxiety disorders.
    Baldwin DS; Reines EH; Guiton C; Weiller E
    Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial.
    Muller JE; Wentzel I; Koen L; Niehaus DJ; Seedat S; Stein DJ
    Int Clin Psychopharmacol; 2008 Jan; 23(1):43-8. PubMed ID: 18090507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escitalopram: efficacy and tolerability in the treatment of depression.
    Baldwin DS
    Hosp Med; 2002 Nov; 63(11):668-71. PubMed ID: 12474611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding and treating depression in Alzheimer's patients: a study of the effects on patients and caregivers.
    Pfeiffer E; Baxter D; Candelora E; Haag S; Nadiminti L; Leaverton P
    Psychopharmacol Bull; 1997; 33(4):721-9. PubMed ID: 9493485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
    Langworth S; Bodlund O; Agren H
    J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.